Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor

被引：0

作者：

Cascino, TL

Veeder, MH

Buckner, JC

OFallon, JR

Wiesenfeld, M

Levitt, R

Goldberg, RM

Kuross, SA

Morton, RF

Scheithauer, BW

机构：

[1] ILLINOIS ONCOL RES ASSOC,COMMUNITY CLIN ONCOL PROGRAM,PEORIA,IL 61602

[2] CEDAR RAPIDS ONCOL PROJECT,CCOP,CEDAR RAPIDS,IA 52403

[3] MERITCARE HOSP,CCOP,FARGO,ND 58123

[4] GEISINGER CLIN ONCOL PROGRAM,DANVILLE,PA 17822

[5] DULUTH COMMUNITY CLIN ONCOL PROGRAM,DULUTH,MN 55805

[6] IOWA ONCOL RES ASSOC,CCOP,DES MOINES,IA 50314

来源：

JOURNAL OF NEURO-ONCOLOGY | 1996年 / 30卷 / 03期

关键词：

recurrent glioma; 5-fluorouracil; leucovorin; radiation therapy; astrocytoma; oligodendroglioma;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thirty patients with recurrent primary brain tumors were treated with a combination of 5-fluorouracil and leucovorin. There were three responses seen. Toxicity consisted of stomatitis, diarrhea, and hematological suppression. 5-fluorouracil and leucovorin would appear to be minimally effective in recurrent brain tumors.

引用

页码：243 / 246

页数：4

共 50 条

[41] A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies
Blanke, CD
Stipanov, M
Morrow, J
Rothenberg, M
Chinery, R
Shyr, Y
Coffey, R
Johnson, DH
Leach, SD
Beauchamp, RD
INVESTIGATIONAL NEW DRUGS, 2001, 19 (01) : 21 - 27
[42] A PHASE-II STUDY OF 5-FLUOROURACIL CISPLATINUM IN RECURRENT CERVICAL-CANCER
KAERN, J
TROPE, C
ABELER, V
IVERSEN, T
KJORSTAD, K
ACTA ONCOLOGICA, 1990, 29 (01) : 25 - 28
[43] A Phase I Study of Vitamin E, 5-Fluorouracil and Leucovorin for Advanced Malignancies
Charles D. Blanke
Michael Stipanov
Jason Morrow
Mace Rothenberg
Rebecca Chinery
Yu Shyr
Robert Coffey
David H. Johnson
Steven D. Leach
R. Daniel Beauchamp
Investigational New Drugs, 2001, 19 : 21 - 27
[44] Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer
Lee, H. J.
Yun, H. J.
Kim, S.
Cho, D. Y.
Park, J. C.
Park, S. Y.
Bae, S. B.
Lee, K. T.
Cho, I. S.
Han, C. S.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 427 - 432
[45] Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer
Hyo Jin Lee
Do Yeun Cho
Ji Chan Park
Sang Byung Bae
Kyu Taek Lee
In Sung Cho
Chang Soon Han
Suk Young Park
Hwan Jung Yun
Samyong Kim
Cancer Chemotherapy and Pharmacology, 2009, 63
[46] A PHASE-II STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND INTERFERON-ALPHA IN ADVANCED PANCREATIC-CANCER
MOORE, MJ
ERLICHMAN, C
KAIZER, L
FINE, S
ANTI-CANCER DRUGS, 1993, 4 (05) : 555 - 557
[47] Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2)
André, T
Noirclerc, M
Hammel, P
Meckenstock, R
Landi, B
Cattan, S
Selle, F
Codoul, JF
Guerrier-Parmentier, B
Mokhtar, R
Louvet, C
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (8-9): : 645 - 650
[48] Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients
Si Sun
Lei Ping Wang
Jian Zhang
Xiao Yan Yang
Qun Ling Zhang
Zhen Jia
Xi Chun Hu
Bi Yun Wang
Medical Oncology, 2012, 29 : 418 - 424
[49] Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: A phase II study
Yang, TS
Chen, JS
Tang, RP
Chiang, JM
Hsieh, PS
Yeh, CY
Changchien, CR
CHEMOTHERAPY, 2003, 49 (04) : 194 - 199
[50] An open-label, phase I/II study of 5-fluorouracil plus leucovorin in the treatment of rheumatoid arthritis
Bunch, TW
Erlichman, C
Luthra, HS
Matteson, EL
JOURNAL OF RHEUMATOLOGY, 2002, 29 (05) : 1109 - 1110

← 1 2 3 4 5 →